Pulsenmore Ltd Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Monitoring Framework
Key Performance Indicators
Annual Revenue Annually12.5MTarget: Accelerate commercial momentum and expand recurring revenue streams in the U.S. market
Net Loss Annually-5MTarget: Narrow losses through disciplined investment and scaling of U.S. infrastructure
Total Liquid Assets Quarterly21.7MTarget: Maintain sufficient liquidity to fund operations and U.S. commercial rollout
Watch Items
- U.S. Commercial Rollout and PartnershipsTrigger: Expansion of services agreements with key maternal-fetal medicine practices and virtual maternity care providersAction: Monitor execution of partnerships with Ouma Health, TLC Perinatal PA, and the Center for Fetal Medicine & Women's Ultrasound
- Capital Requirements and Cash RunwayTrigger: Depletion of liquid assets below operational safety marginsAction: Evaluate the utilization of the $7.5 million private placement closed in June 2026 and assess the need for additional capital raises
- Regulatory and AI Development MilestonesTrigger: Progress on the $1 million AI development project with the Israel Innovation Authority and Ministry of HealthAction: Track development timelines and integration of AI features into the home-use ultrasound platform
Research as of 24 Jul 2026